TAI Diagnostics
2015
FOUNDED
PRIVATE
STATUS
Series A
LATEST DEAL TYPE
$12.8M
LATEST DEAL AMOUNT
3
INVESTORS
Description
Developer of a non-invasive and highly sensitive diagnostic test designed to monitor the health of transplanted organs. The company's proprietary non-invasive assay which utilizes cf-DNA technology as a direct measurement of organ injury through quantitation of donor-specific cf-DNA released into the bloodstream from injured cells of a transplanted organ, enabling physicians to detect rejection early and perform surveillance biopsies at regular intervals caused by a deletion from chromosome 22 at the q11 location.
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Laboratory Services (Healthcare)
Primary Office
- 10101 Innovation Drive
- Suite 600
- Milwaukee, WI 53226
- United States
+1 (414) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore TAI Diagnostics’s full profile, request a free trial.
TAI Diagnostics Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC (Series A) | 08-Jan-2018 | $12.8M | 000.00 | 000.00 | Completed | Generating Revenue |
| 1. Early Stage VC (Series A) | 23-Oct-2015 | 00.00 | 00.00 | 0000 | Completed | Startup |
TAI Diagnostics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | 00,000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
TAI Diagnostics Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| United Therapeutics | Corporation | Minority | 000 0000 | 000000 0 | ||
| Venture Investors | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Wisconsin Economic Development Corporation | Lender/Debt Provider | Minority | 000 0000 | 000000 0 |
TAI Diagnostics Executive Team (2)
| Name | Title | Board Seat |
Contact Info |
|---|---|---|---|
| Frank Langley | Chief Executive Officer & Board Member | ||
| Aoy Tomita-Mitchel Ph.D | Co-Founder, Board Director & Chief Scientific Officer |
TAI Diagnostics Board Members (5)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Aoy Tomita-Mitchel Ph.D | TAI Diagnostics | Co-Founder, Board Director & Chief Scientific Officer | 000 0000 | |
| Frank Langley | TAI Diagnostics | Chief Executive Officer & Board Member | 000 0000 | |
| John Fowler | Self | Board Member | 000 0000 | |
| John Neis | Venture Investors | Board Member | 000 0000 | |
| Michael Mitchell MD | Self | Co-Founder, Chief Clinical Advisor & Board Member | 000 0000 |